Leukotriene Signaling as a Target in α-Synucleinopathies
Parkinson’s disease (PD) and dementia with Lewy bodies (DLB) are two common types of α-synucleinopathies and represent a high unmet medical need. Despite diverging clinical manifestations, both neurodegenerative diseases share several facets of their complex pathophysiology. Apart from α-synuclein a...
Main Authors: | Katharina Strempfl, Michael S. Unger, Stefanie Flunkert, Andrea Trost, Herbert A. Reitsamer, Birgit Hutter-Paier, Ludwig Aigner |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/12/3/346 |
Similar Items
-
The Leukotriene Receptor Antagonist Montelukast Attenuates Neuroinflammation and Affects Cognition in Transgenic 5xFAD Mice
by: Johanna Michael, et al.
Published: (2021-03-01) -
The Pharmacology of Visual Hallucinations in Synucleinopathies
by: Mirella Russo, et al.
Published: (2019-12-01) -
Sex differences in alpha-synucleinopathies: a systematic review
by: Kausar Raheel, et al.
Published: (2023-07-01) -
Peripheral blood inflammatory cytokines in prodromal and overt α-synucleinopathies: a review of current evidence
by: Jin-Sun Jun, et al.
Published: (2023-07-01) -
Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies
by: Ichiro Kawahata, et al.
Published: (2022-06-01)